Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism.

Jennifer L FanLaura E RobertsMichael E ScheurerDonald L YeeMona D ShahYoungNa J Lee-Kim

Published in: Pediatric blood & cancer (2017)

There was no statistically significant difference between low-range versus high-range mean anti-Xa levels and thrombus resolution. Empiric clinical practices of targeting anti-Xa levels in the higher therapeutic range to achieve better outcomes may not be warranted.

Keyphrases

venous thromboembolism
primary care
type diabetes
metabolic syndrome
direct oral anticoagulants
drug delivery
cancer therapy
young adults